Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04068727 · ClinicalTrials.gov registry record · NA
LEAVE Safe With DOACs
A NA study of Stroke and Cardiovascular Diseases, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 561
- Enrollment target
- 1
- Study location
NCT04068727: Completed NA study of Stroke and Cardiovascular Diseases, sponsored by University of Massachusetts, Worcester.
NCT04068727 is a NA study of Stroke and Cardiovascular Diseases that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 561 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04068727, a NA study of Stroke and Cardiovascular Diseases, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 561 participants
- Enrollment target
- 1
- Study location
Study Summary
Given the risks associated with direct oral anticoagulants (DOACs) and the lack of defined pathways for patients prescribed this class of medications, the study intervention has the potential for an enormous impact in preventing medication errors and improving the quality of care transition, patient knowledge, and adherence with DOAC therapy.
Primary Outcome
The number of preventable, ameliorable and potential Adverse Drug Events (ADEs) that physician reviewers attribute to Direct Oral Anticoagulant (DOAC) medication. Each DOAC related clinically important medication error is counted as a separate event, enabling patients to have multiple events consistent with the literature.
Conditions Studied
Interventions
- OTHER Clinical Pharmacist Intervention
Study Locations (1)
Massachusetts
- UMass Memorial Medical Center - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 561 participants |
| Start Date | 2019-12-02 |
| Est. Completion | 2022-09-14 |
| Phase | NA |
What the finished NCT04068727 record still lists
NCT04068727 is an interventional study that assigns participants to a tested intervention. The registered 561 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Clinical Pharmacist Intervention is the first listed.
NCT04068727 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04068727 about?
NCT04068727 is a clinical study titled "LEAVE Safe With DOACs". Given the risks associated with direct oral anticoagulants (DOACs) and the lack of defined pathways for patients prescribed this class of medications, the study intervention has the potential for an enormous impact in preventing medication errors and improving the quality of care transition, patient...
What is the current status of trial NCT04068727?
This trial is currently completed. It is a NA study. The enrollment target is 561 participants. The study started on 2019-12-02. Estimated completion is 2022-09-14.
What conditions does trial NCT04068727 study?
This clinical trial studies the following conditions: Stroke, Cardiovascular Diseases, Atrial Fibrillation, Venous Thromboembolism, Bleeding.
What interventions are being tested in trial NCT04068727?
The interventions under investigation include: Clinical Pharmacist Intervention (OTHER).
Who is sponsoring clinical trial NCT04068727?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04068727 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04068727's enrollment target sits among peer trials
561 53rd of 454 higher than 402 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07007065 · 561 participants · Phase 3
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
- NCT04661358 · 560 participants · Phase 3
Fenofibrate for Prevention of DR Worsening
- NCT05473871 · 560 participants · NA
Enhancing Capacity in Churches to Implement PA Programs
- NCT06001541 · 560 participants · NA
Web-based Program to Improve Self-management Among Veterans-caregiver Dyads
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI